Osprey Medical Inc. (ASX:OSP) CEO Mike McCormick tells Proactive this week the firm announced a 4-year partnership with GE Healthcare, who will distribute Osprey’s product portfolio in Europe, Russia, Middle East, Africa, Central Asia and Turkey. McCormick says this is a 'big step' for the Minneapolis-based firm, where GE Healthcare will sell Osprey’s DyeVert contrast minimization devices, a technology platform to address Acute Kidney Injury following interventional coronary angiograms in patients with Chronic Kidney Disease.
Osprey Medical forms distribution partnership with med-tech giant GE Healthcare
Quick facts: Osprey Medical Ltd
Price: 0.03 AUD
Market Cap: $89.93 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE